Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

These two reports address the effects of varicella-zoster vaccination and varicella vaccination. Richard Whitley, who chaired the data and safety monitoring board for the Shingles Prevention Study ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

CINCINNATI (WKRC) - A new study suggests that getting the vaccine to protect against shingles may be good for your memory as well. "So, shingles is the chicken pox virus that comes out later in ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

In persons aged 50 years and over (i.e., 40% of the European population by 2020), HZ and its most common complication PHN cause significant morbidity and pain, reduced QoL and loss of dependency.

National Immunization Awareness Month is observed each August to highlight the importance of vaccination for people of all ages. Some vaccinations are recommended for older adults include flu, RSV and ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline ...

reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...